GROW GROUP INC
10-Q, 1995-05-15
PAINTS, VARNISHES, LACQUERS, ENAMELS & ALLIED PRODS
Previous: GROW GROUP INC, SC 14D1/A, 1995-05-15
Next: HADRON INC, 10-Q, 1995-05-15



                    SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C.  20549

                              FORM 10-Q

     (X)  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
          EXCHANGE ACT OF 1934

     For the quarter ended March 31, 1995

          OR

     ( )  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
          EXCHANGE ACT OF 1934

     For the transition period from _______________ to _______________

     Commission file number 1-4596

                              GROW GROUP, INC.                        
     ________________________________________________________________________
               (Exact name of registrant as specified in its charter)

               New York                             11-1665588        
     ________________________________________________________________________
     (State or other jurisdiction of             (IRS Employer
      incorporation or organization)           Identification No.)

               200 Park Avenue, New York, New York      10166         

     ________________________________________________________________________
          (Address of principal executive offices)   (Zip Code)

     Registrant's telephone no., including area code:  (212) 599-4400
                                                      ________________

                               Not Applicable                         
     _________________________________________________________________________
     (Former name, former address and former fiscal year, if changed since 
     last report)

          Indicate by check mark whether the registrant (1) has filed
     all reports required to be filed by Section 13 or 15(d) of the
     Securities Exchange Act of 1934 during the preceding 12 months
     (or for such shorter period that the registrant was required to
     file such reports), and (2) has been subject to such filing
     requirements for the past 90 days.

                              Yes   X    No      
                                   _____    ______

          The number of shares of Common Stock, $.10 par value per
     share, outstanding as of May 10, 1995 was 16,101,712.



                              GROW GROUP, INC.

                                   INDEX
                                   _____

     PART I.   FINANCIAL INFORMATION                   PAGE NUMBER
                                                       ___________

               Item 1.  Financial Statements

               Consolidated Condensed Balance Sheet          3
               (Unaudited) - March 31, 1995 and
               June 30, 1994

               Consolidated Condensed Statement of           4
               Operations (Unaudited) - Nine Month
               and Three Month Periods Ended
               March 31, 1995 and March 31, 1994

               Consolidated Condensed Statement of           5
               Cash Flows (Unaudited) - Nine Months
               Ended March 31, 1995 and
               March 31, 1994

               Notes to Consolidated Condensed               6
               Financial Statements (Unaudited)

               Item 2.  Management's Discussion and          7
                        Analysis of Financial Condition
                        and Results of Operations

     PART II.  OTHER INFORMATION

               Item 1.  Legal Proceedings                   10

               Item 5.  Other Information                   14

               Item 6.  Exhibits and Reports on Form 8-K    15


                           PART I:  FINANCIAL INFORMATION
                         GROW GROUP, INC. AND SUBSIDIARIES
                           CONSOLIDATED CONDENSED BALANCE
                               SHEET (UNAUDITED)

                                                 March       June
                                                   31,        30,
                                                  1995       1994
                                             ____________    __________
                                                    (In thousands)

     ASSETS
     CURRENT ASSETS
      Cash and cash equivalents                   $ 5,084    $38,816
      Accounts receivable less allowances
       of $4,814 and $3,667                        69,745     69,622
      Inventories, at lower of cost or market:
       Finished and in-process products            68,794     48,490
       Materials, containers and supplies          17,530     14,413
                                              ____________  ___________
                                                   86,324     62,903
      Prepaid expenses and other current
       assets                                      16,958     16,052
                                               ___________  ___________
          Total current assets                    178,111    187,393

     PROPERTY, PLANT AND EQUIPMENT, at cost       136,119     99,331
     Less allowance for depreciation               52,740     48,524
                                               ___________  ___________
                                                   83,379     50,807
     OTHER ASSETS                                  25,058      9,721   
                                               ___________  ___________
          TOTAL ASSETS                           $286,548   $247,921   
                                               ===========  ===========
     LIABILITIES AND STOCKHOLDERS' EQUITY
     CURRENT LIABILITIES
      Accounts payable                           $ 37,810   $ 37,532
      Accrued expenses                             36,497     29,036
      Income taxes                                  5,562     10,180
      Dividend payable                              1,127      1,128
      Current installments on long-term debt        4,343      2,270   
                                                __________  ___________
          Total current liabilities                85,339     80,146

     DEFERRED INCOME TAXES AND OTHER LIABILITIES   28,168     28,178

     LONG-TERM DEBT                                32,834        914
     STOCKHOLDERS' EQUITY
     Common stock, par value $.10 per share:
          Authorized 50,000,000 shares;
           issued 16,271,831 shares                 1,627      1,627
     Less treasury stock at cost
          (170,118 and 168,493 shares)             (1,384)    (1,345)
     Paid-in-capital                              123,432    123,428
     Equity adjustments                                39        (49)
     Deferred compensation                         (2,601)    (2,907)
     Retained earnings                             19,094     17,929   
                                                __________  ___________
                                                  140,207    138,683   
                                                __________  ___________
          TOTAL LIABILITIES AND
           STOCKHOLDERS' EQUITY                  $286,548   $247,921   
                                                __________  ___________


                       GROW GROUP, INC. AND SUBSIDIARIES
           CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS (UNAUDITED)
                      (In thousands except per share data)

                                  Nine Months Ended    Three Months Ended
                                        March 31           March 31   
                                 __________________     __________________
                                 1995        1994       1995         1994  
                                 __________________     __________________
     Revenues                    $364,063   $288,566    $117,824   $91,180 
      Costs and expenses:
      Cost of products sold       234,510    184,135      77,210    59,436
      Research and development      4,497      3,539       1,511     1,226
      Storage and delivery         13,329     11,856       4,624     4,019
      Selling and administrative  101,858     76,490      34,965    24,288
      Interest expense              1,928        683         764       235
      Corporate interest income      (259)      (710)        (51)     (227)
     Unusual Item                      79          0          19         0
                                  ________   ________    ________   ________
     Total costs and expenses     355,942    275,993     119,042    88,977
                                  ________   ________    ________   ________
     Income before income taxes     8,121     12,573      (1,218)    2,203
     Income taxes                   3,573      5,281        (350)      925
                                  ________   ________    ________   _______
     Net Income                  $  4,548   $  7,292    $  ($868)  $ 1,278
                                  ========   ========    ========   =======
     Net income per common and
     common equivalent share         $.28       $.45       $(.05)     $.08
                               ========== ==========  =========== ========= 
     Average number of shares  16,150,000 16,100,000  16,144,000 16,155,000
                               ========== ==========  ========== ==========
     Cash dividends per share
           (common)                  $.21       $.21        $.07      $.07
                               ========== ==========  ==========  ========= 
 

                      GROW GROUP, INC. AND SUBSIDIARIES
          CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS (UNAUDITED)

                                                   Nine Months Ended
                                                        March 31    
                                                  ___________________
                                                    1995        1994
                                                  ___________________
                                                     (In thousands)

     Operating Activities

      Net income                                  $ 4,548   $ 7,292
      Adjustments to reconcile net income
       to net cash provided (used)
       by operating activities:
        Depreciation, amortization and
         provision for doubtful accounts            8,048     7,048
        Changes in operating assets and
         liabilities-net                          (15,140)  ( 2,361)
     Other                                           (218)     (557)
                                                 _____________________
          Net cash provided (used) by
           operating activities                  $ (2,762)  $11,422

     Investing Activities

      Purchase of property, plant and
       equipment - net of disposals                (5,764)   (3,847)
      Acquisition of Sinclair (FY1995) and
       Zynolyte and Havco (FY1994)                (55,781)  (17,389)
                                                  _____________________
           Net cash used by
            investing activities                 $(61,545) $ (21,236)

     Financing Activities

      Proceeds from borrowing/payments of
       debt - net                                  33,993    (5,123)
      Proceeds from issuance of common stock -
       net of purchases                               (35)      898 
      Cash dividends                               (3,383)   (3,419)
                                                  _____________________
          Net cash provided (used) by
           financing activities                  $ 30,575  $ (7,644)
                                                  _____________________
          (Decrease) in cash and
            cash equivalents                      (33,732)  (17,458)

     Cash and cash equivalents at beginning
      of period                                  $ 38,816  $ 56,015
                                                  _____________________

     Cash and cash equivalents at end
      of period                                   $ 5,084  $ 38,557
                                                   ====================


          NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (UNAUDITED)

     a.  The accompanying unaudited consolidated condensed financial
     statements have been prepared in accordance with generally
     accepted accounting principles for interim financial information
     and with the instructions to Form 10-Q and Regulation S-X. 
     Accordingly, they do not include all the information and
     footnotes required by generally accepted accounting principles
     for complete financial statements.  In the opinion of management,
     all adjustments (consisting of normal recurring accruals)
     considered necessary for a fair presentation have been included. 
     Operating results for the three month and nine month periods
     ended March 31, 1995 are not necessarily indicative of the
     results that may be expected for the year ending June 30, 1995. 
     For further information, refer to the consolidated financial
     statements and footnotes thereto included in the Company's Annual
     Report on Form 10-K for the year ended June 30, 1994.

     b.  Effective August 2, 1993, the Company purchased all of the
     outstanding capital stock of Zynolyte Products Company
     ("Zynolyte") for $16,300,000 in cash.  Zynolyte is a producer of
     aerosol and specialty brush-applied paint products.  Its annual
     revenues were approximately $27 million for the year ended
     January 31, 1993.

     c.  Effective August 1, 1994, the Company acquired substantially
     all of the assets and assumed certain liabilities of Sinclair
     Paint Company ("Sinclair"), a division of Insilco Corporation,
     for approximately $56 million in cash.  Sinclair's revenues for
     calendar year 1993 were approximately $95 million.  The
     transaction resulted in approximately $15 million in cost in
     excess of net assets acquired which is being amortized over 40
     years.

          The following unaudited pro forma summary presents the
     consolidated results of operations as if the acquisition of
     Sinclair had occurred at the beginning of the periods presented
     and does not purport to be indicative of what would have occurred
     had the acquisition been made as of those dates or of results
     which may occur in the future.

                              For the Nine Months  For the Three
                                 Ended March 31    Months Ended
                               1995       1994     March 31, 1994
                              ________  ________   ______________

     Revenues                 $374,138  $361,706       $114,258
                              ========  ========       ======== 
     Net income               $  5,215  $  6,141       $    839
                              ========  ========       ========
     Net income per 
     common and common 
     equivalent share         $   0.32  $   0.38       $   0.05
                              ========  ========       ========

     d.  To finance the acquisition, the Company's revolving loan
     facility, with Chemical Bank as agent, was increased from $40
     million to $60 million and $26 million was borrowed thereunder. 
     During the quarter ended December 31, 1994, the revolving loan
     facility was further increased to $75 million and Wells Fargo
     Bank became a participant. In addition, during the quarter ended
     March 31, 1995, the facility was extended for one year to March
     31, 1997.

     e.  On April 30, 1995 the Company entered into an Agreement and
     Plan of Merger among the Company, Imperial Chemical Industries
     PLC ("ICI") and GDEN Corporation, an indirect wholly-owned
     subsidiary of ICI.  Pursuant to the Agreement and Plan of Merger,
     on May 4, 1995 a tender offer was commenced by GDEN Corporation
     for all shares held by stockholders of the Company at $18.10 per
     share.  On May 8, 1995, The Sherwin-Williams Company through its
     wholly-owned subsidiary, GGI Acquisition, Inc., commenced a
     tender offer for all outstanding shares at $19.50 per share.  See
     Part II, Item 5, "Other Information" below for a more complete
     description of these tender offers.

          The Company has been named as a defendant in a number of law
     suits (including purported class actions) in connection with the
     transactions contemplated by the Agreement and Plan of Merger and
     tender offers.  (See Part II, Item 1, "Legal Proceedings" below).

     ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
               CONDITION AND RESULTS OF OPERATIONS

                    Quarter and Nine Months Ended March 31, 1995
               Compared to Quarter and Nine Months Ended March 31, 1994

     General

          As more fully described in Part II, Item 5, "Other
     Information" below, the Company has entered into an Agreement and
     Plan of Merger and competing tender offers have been commenced.  
     The Company's results of operations and financial position for 
     the fourth quarter and future periods may be impacted by certain
     costs and expenses (including cash and non-cash charges) which
     are being or may be incurred in connection with such tender 
     offers.  Such items include, but are not limited to, legal,
     accounting and other fees and expenses presently estimated at
     approximately $3,000,000, the write off of certain deferred
     financing costs of approximately $250,000 if an offer is consummated, 
     a "breakup fee" of $8,000,000 which may become payable to ICI 
     under certain circumstances, a non cash charge to earnings related 
     to forgiveness of an Employee Stock Ownership Plan loan of
     approximately $2,600,000 if an offer is consummated, and unusual 
     travel and other expenses in a presently indeterminable amount.  
     Certain of the foregoing legal, accounting and other charges will 
     be incurred whether or not the foregoing tender offers are consummated.

     Results of Operations

          Consolidated revenues increased $75,497,000 (26.2%) for the
     nine months and $26,644,000 (29.2%) for the quarter.  The
     increases were primarily the result of including the revenues of
     Sinclair Paint Company ("Sinclair") acquired effective August 1,
     1994.  Revenues of the Company's operations exclusive of Sinclair
     increased $8,197,000 (2.8%) for the nine months and $4,650,000
     (5.1%) for the quarter.

          Revenues of the coatings and chemicals segment increased
     $72,788,000 (31.0%) in the nine months and $25,710,000 (35.5%) in
     the third quarter with Sinclair accounting for most of such
     increases.  Revenues from Architectural Paint operations, other
     than Sinclair, increased 4.7% in the nine months and 5.4% in the
     quarter.  The increases were principally the result of higher
     sales of sundries (such as brushes and rollers, wallpaper and
     other accessory items and application equipment) and sales
     contributed by an increased number of company-operated stores
     offset, in part, by lower royalty income.  In addition, for the
     quarter, lower sales of both aerosols and specialties were
     recorded by Zynolyte Products Company.  Sales were stronger for
     the Company's Devoe & Raynolds operation which sells east of the
     Rocky Mountains and softer in both California (which experienced
     bad weather) and Hawaii where Ameritone Paint Company operates. 
     Automotive Division revenues decreased 8.2% in the nine months
     and 5.7% in the quarter as a result of both lower unit volume and
     lower pricing due to competitive pressures.  Devoe Coatings
     Company Division (maintenance and marine products) revenues
     declined by .9% in the nine months and increased 10.0% in the
     quarter.  Revenues for this Division in the current fiscal year
     were adversely impacted by 4.7% in the nine months and 1.0% in
     the quarter.  Decreased sales in the highly competitive European
     market had a negative impact in both the nine months and the
     third quarter.

          Revenues of the Consumer and Professional Products segment
     increased $2,709,000 (5.0%) in the nine months and $934,000
     (4.7%) in the quarter.  Higher unit volume in sales to club
     stores (including new products introduced to this market in the
     second quarter) and higher unit volume for the Consumer Division
     in each of the first three quarters of fiscal 1995 were offset,
     in part, by lower sales of Professional Products.  Revenues were
     also adversely impacted by competitive price reductions.

          Cost of Products Sold:  Consolidated gross profit as a
     percentage of revenues decreased slightly from 36.2% to 35.6% for
     the nine months and from 34.8% to 34.5% for the quarter.  The
     impact of including Sinclair (which operates, as do the Company's
     other architectural paint operations, at somewhat higher gross
     profit margins than some of the Company's other operations) had
     the effect of increasing the gross profit percentage by 9/10 of
     one percentage point for the nine months and 1.5 percentage
     points for the quarter.  This was offset by lower margins in
     Devoe Coatings marine and maintenance products, Consumer and
     Professional Products Group and the Automotive Division. Gross
     profit margins for the Devoe Coatings operations decreased by 1.3
     percentage points in the nine months and 2.5 percentage points in
     the quarter reflecting highly competitive conditions,
     particularly in the domestic marine business, higher raw material
     costs and reduced contracting and royalty revenue.  The reduction
     in the gross margin percentage of the Consumer and Professional
     Products Group (3.0 percentage points for the nine months and 2.8
     percentage points for the quarter) was related principally to
     competitive price reductions and raw material cost increases. 
     This operation has implemented selling price increases for the
     second half of fiscal 1995.  The Automotive Division experienced
     raw material cost increases which have not yet been passed on to
     customers.  Architectural paint operations have been and are
     expected to continue to experience selective raw material cost
     increases.  Selling price increases have been implemented and
     further action will be taken when feasible to maintain gross
     profit margins.

          Storage and Delivery:  The increases of $1,473,000 (12.4%)
     for the nine months and $605,000 (15.1%) for the quarter are
     primarily the result of including Sinclair along with a change in
     the mix of shipments in the Consumer and Professional Products
     Group.

          Selling, General and Administrative:  The increases of
     $25,368,000 (33.2%) for the nine months and $10,677,000 (44.0%)
     for the quarter were primarily the result of including Sinclair
     ($22,284,000 for the nine months and $7,983,000 for the quarter)
     in the current periods.  Sinclair, as with the Company's other
     architectural paint operations, has higher SG&A expenses as a
     percentage of revenues than the Company as a whole.  This was a
     factor in the increase in the percentage of SG&A expenses to
     revenues in the fiscal 1995 periods.  In both the nine months and
     the quarter product introduction costs for Foam & FreshTM  were
     incurred by the Consumer and Professional Products Group,
     architectural paint operations incurred higher store operating
     costs due to opening new locations (including the acquisition of
     five Havco Paint stores in the Tampa area) and product
     introduction costs related to AquanamelTM and DevlokTM were
     experienced.  Also affecting SG&A expense were expenditures
     related to the start-up of the Consumer Paint Division, legal
     expenses regarding a case won by a jury verdict, costs related to
     a management change in the Automotive Division, and costs
     incurred on the aborted proposed acquisitions of Martin Paint and
     a company in Spain.  In addition, the first six months of the
     current year included unusual costs related to the relocation of
     a large store in Honolulu.  The absence of such expenses would
     have resulted in lower SG&A expense including lower environmental
     costs - See Environmental Matters.

          Interest Expense and Corporate Interest Income:  The net
     increase ($1,696,000 for the nine months and $705,000 for the
     quarter) in these items was primarily the result of increased
     borrowings and the use of cash balances for the acquisition of
     Sinclair.  Increases in prevailing interest rates also
     contributed to the net increase.

          Environmental Matters:  The Company continues to incur and
     accrue costs related to compliance with environmental laws.  The
     provision for such costs amounted to $910,000 for the nine months
     and $408,000 for the quarter ended March 31, 1995 compared to
     $2,213,000 for the prior year's nine months and $602,000 for the
     prior year's quarter.  The Company periodically reviews its
     estimates of and accrues appropriate amounts for costs of
     compliance with environmental laws and the cleanup of various
     sites, including sites as to which governmental agencies have
     designated the Company (or have indicated a possibility of
     designating the Company) a potentially responsible party.  (See
     the Company's Annual Report on Form 10-K for the year ended June
     30, 1994).  The provisions for environmental costs for the
     periods ended March 31, 1995 are not necessarily indicative of
     future costs.

        Where a minimum cost or a reasonable estimate of the total
     costs of cleanup or compliance has been established, the
     applicable amount has been accrued. The related accrued liability
     totalled $10,093,000 as of December 31, 1994.  In many instances,
     estimates cannot be made of the total costs of cleanup or
     compliance, the Company's share, if any, of such costs, nor the
     timing thereof; accordingly, the Company is unable to predict the
     effect thereof on future results of operations.  In the event of
     one or more adverse determinations in any annual or interim
     period, the impact on results of operations for those periods
     could be material.  However, based upon the Company's present
     belief as to its relative involvement at these sites, other
     viable entities' responsibilities for cleanup, potential
     insurance coverage and the extended period over which any costs
     would be incurred, the Company presently believes that these
     matters will not have a material adverse effect on the Company's
     consolidated financial position.

          Income taxes:  The effective income tax rate used for the
     nine months increased from 42% to 44% due to an increase in non-
     deductible losses in the Netherlands subsidiary.  The change in
     the quarter is the result of using the new effective tax rate for
     the year-to-date calculation.

     LIQUIDITY:

          During the nine months, operating activities used $2,762,000
     of cash flow.  The Company's net income, adjusted for
     depreciation, amortization and provision for doubtful accounts,
     contributed $12,596,000 to cash flow.  Changes in operating
     assets and liabilities and other items used $15,358,000 in cash
     flow.  The changes in all balance sheet categories were primarily
     the result of the inclusion of the operations of Sinclair and
     normal seasonal patterns.

          The acquisition of the assets of Sinclair for approximately
     $56 million in cash and net purchases of fixed assets of
     $5,764,000 resulted in a use of cash for investing activities of
     $61,545,000.

          To finance the acquisition of Sinclair, and for working
     capital, the Company borrowed $32 million under its revolving
     credit line (which has a current interest rate of approximately 8
     1/8%).  After giving effect to cash dividends paid of $3,383,000
     and certain other items, net cash provided by financing
     activities was $30,575,000.

          The Company has a revolving credit facility expiring in
     March 1997 with four banks to borrow, at prime (or, at the
     Company's option, LIBOR plus 2%) up to $75 million less the
     amount of outstanding letters of credit ($13,693,000 at March 31,
     1995).  Future short-term and long-term liquidity requirements,
     including amounts required for acquisitions, are expected to be
     satisfied from cash flow from operations, borrowings from banks
     or other lenders and/or equity sources.

          The Company's liquidity may be affected by the costs and
     expenses described under "General" above and the Company's
     lenders may be entitled to terminate the Company's revolving
     credit facility as a result of the transactions contemplated by
     the Agreement and Plan of Merger.

          See Note d to the financial statements.

                                   PART II
                              OTHER INFORMATION

     Item 1.   Legal Proceedings.
               _________________

          (a)  On February 14, 1995, a complaint was served on the
     Company in an action entitled Hobart Walters, Sr. & Quality Paint
     & Decorating v. Grow Group, Inc., Devoe & Raynolds Co., Rey Gomez
     and Malcolm R. (Sonny) Dobb, which was filed in the 129th
     Judicial District Court, Harris County, Texas.  The action was
     removed to the United States District Court for the Southern
     District of Texas, Houston Division.  The complaint alleges that
     the Company's Devoe & Raynolds Co. Division violated the Texas
     Deceptive Trade Practices Act by making certain false, misleading
     and deceptive statements regarding a Dealer Agreement between
     Quality Paint & Decorating and Devoe & Raynolds Co.  The
     complaint also alleges causes of action for common law fraud,
     breach of contract, antitrust violation, negligent
     misrepresentation and fraudulent concealment in connection with
     the course of dealing between Quality Paint & Decorating and
     Devoe & Raynolds Company.  The complaint does not seek relief in
     a specific dollar amount.

          (b)  On April 30, 1995, the Company entered into an
     Agreement and Plan of Merger (the "Merger Agreement"), dated as
     of April 30, 1995, with Imperial Chemical Industries PLC ("ICI"),
     and GDEN Corporation, an indirect wholly-owned subsidiary of ICI
     ("GDEN"), which provides, among other things, for the acquisition
     by ICI of all the outstanding shares of the Company's Common
     Stock, $.10 par value per share (the "Shares"), through a tender
     offer (the "ICI Offer") for $18.10 per Share.  Corimon, S.A.C.A.
     ("Corimon") entered into an Option Agreement, dated as of April
     30, 1995, with ICI and GDEN (the "Corimon Option Agreement")
     pursuant to which Corimon granted ICI an option to purchase
     4,025,841 Shares (approximately 25% of the outstanding shares of
     the Company's Common Stock) at a purchase price of $17.50 per
     Share.  ICI's purchase of the Shares owned by Corimon is
     conditioned upon ICI's prior consummation of its tender offer. 
     The Merger Agreement, the ICI Offer and the Option Agreement are
     more fully described in Item 5 "Other Information" below.  In
     connection with the Merger Agreement and the ICI Offer, on May 1,
     1995, a purported class action entitled General Color Company
     Pension Plan v. Grow Group, Inc. et al., was filed in the Supreme
     Court of the State of New York, New York County (the "State
     Action") on behalf of the class of all the Company's current
     shareholders.  In addition to the Company, all members of the
     Company's Board of Directors are named as defendants in the State
     Action.  The complaint in the State Action alleges that the
     $18.10 per Share price which ICI is offering for all the
     outstanding Shares is insufficient and that the proposed ICI
     Offer is unfair to the Company's shareholders and represents an
     attempt by the defendants to enrich themselves at the expense of
     the plaintiff class.  The plaintiff in the State Action asserts
     that defendants violated their fiduciary duties to the Company's
     shareholders by allegedly failing adequately to evaluate the
     Company as a potential acquisition candidate; to take adequate
     steps to enhance the Company's value as an acquisition candidate;
     and to create an active and open auction for the Company.  The
     complaint in the State Action further alleges that the defendants
     have wrongfully decided not to solicit proposals or initiate
     discussions with third parties for the acquisition of the
     Company, instead of seeking the highest possible price for the
     Shares of the plaintiff class.  The complaint in the State Action
     seeks, among other things, a preliminary and permanent injunction
     barring defendants from taking any steps to accomplish the
     proposed merger with ICI at a price that is not fair and
     equitable to the plaintiffs and restraining the defendants'
     ability to use their alleged voting control of the Company to
     effect the transaction with ICI.  The complaint also seeks
     unspecified damages for losses suffered and to be suffered by the
     plaintiff class as a result of the acts alleged in the complaint.

          (c)  On May 5, 1995, a purported class action entitled
     Martin Appelbaum and Rosalyn Younger v. Grow Group, Inc., et al.,
     was filed in the Supreme Court of the State of New York, New York
     County (the "Appelbaum State Action") on behalf of the Company's
     shareholders against the Company, all members of the Company's
     Board of Directors (the "Individual Defendants"), and ICI.  The
     complaint alleges that the Individual Defendants have breached
     and are breaching their fiduciary duties to the purported class
     of the Company's shareholders by, among other things, failing to
     respond in a reasonable and informed manner to an expression of
     interest in the Company by The Sherwin-Williams Company
     ("Sherwin-Williams"); and to inform themselves as to other
     potential acquirors or merger partners so as to maximize
     shareholder value.

               The complaint in the Appelbaum State Action seeks,
     among other things, an order:  requiring the defendants to carry
     out their fiduciary duties to plaintiffs and other members of the
     purported class; enjoining the transaction between the Company
     and ICI, and rescinding any transactions effected by the
     defendants in an unfair manner and for an unfair price; damages
     suffered as a result of the acts and transactions alleged in the
     complaint; an accounting for all profits realized as a result of
     the complained of transaction; and costs, disbursements, and
     reasonable attorneys' and experts' fees.

          (d)  On May 5, 1995, a purported class action entitled
     Samuel Pill v. Grow Group, Inc., et al., was filed in the Supreme
     Court of the State of New York, New York County (the "Pill State
     Action") on behalf of the Company's shareholders, against the
     Company and all members of the Company's Board of Directors (the
     "Individual Defendants").  The complaint alleges that the
     Individual Defendants breached their fiduciary duties to the
     purported class of the Company's shareholders by agreeing to the
     ICI transaction at a price which they knew was grossly unfair,
     inadequate and not representative of the true and present value
     of the Company.  The complaint also alleges, among other things,
     that the Individual Defendants have breached their fiduciary
     duties to the purported class by failing to auction the Company
     to the highest bidder.  The complaint further alleges that the
     option granted to ICI to purchase Corimon's 25% interest in the
     Company is a breach of the fiduciary duties owed by defendant
     Broslat, who is a director of the Company and the Chief Financial
     Officer of Corimon.

               The complaint in the Pill State Action seeks, among
     other things, an order declaring that the Individual Defendants
     have breached their fiduciary duties; enjoining defendant from
     proceeding with the transaction; damages in an unspecified
     amount; and costs, disbursements and counsel and expert fees.

          (e)  On May 4, 1995, the Company learned that a purported
     class action entitled Miriam Sarnoff and Frederick Rand v. Grow
     Group, Inc. et al., was filed on May 2, 1995 in the Supreme Court
     of the State of New York, New York County (the "Sarnoff State
     Action") on behalf of the Company's shareholders.  In addition to
     the Company, all members of the Company's Board of Directors are
     named as defendants in the Sarnoff State Action.  The complaint
     in the Sarnoff State Action alleges that the proposed transaction
     with ICI is grossly unfair and detrimental to the Company's
     shareholders.  The complaint asserts that the defendants agreed
     to the proposed transaction with ICI in order to enable the
     defendants to maintain their positions as directors and officers
     of the Company, and to benefit Corimon, which allegedly had an
     incentive to accept a low bid because it needed to raise cash
     quickly in order to fund its recently announced acquisition of
     "Standard Paints" in California.  The complaint further alleges
     that the Merger Agreement prohibits defendants from negotiating
     with third parties, and that as a result, there was no
     possibility that competition between ICI and other companies
     could have driven up the purchase price.  The complaint in the
     Sarnoff State Action seeks, among other relief, an order
     requiring defendants to announce their intention to cooperate
     with any entity having a bona fide interest in proposing a
     transaction that would maximize shareholder value, undertake an
     evaluation of the Company's worth as a merger/acquisition
     candidate, and act independently to protect the shareholders'
     interest.  The complaint also seeks an accounting for damages
     allegedly suffered by shareholders as a result of the acts and
     transaction alleged in the complaint.

          (f)  On May 8, 1995, an action entitled The Sherwin-Williams
     Company v. Imperial Chemical Industries PLC et. al., was filed in
     the United States District Court for the Northern District of
     Ohio, Eastern Division by Sherwin-Williams against ICI, GDEN and
     the Company (the "Sherwin-Williams' Federal Action").  The
     complaint alleges, among other things, that ICI's Offer to
     Purchase, dated May 4, 1995 (the "Offer to Purchase") is
     materially false and misleading, in that it (i) falsely describes
     the break-up fee provisions of the Merger Agreement; (ii)
     misrepresents the terms and nature of the Corimon Option
     Agreement; and (iii) misrepresents ICI's ability to consummate a
     Merger with the Company which, according to the complaint, cannot
     be consummated for five years under Section 912 of the New York
     Business Corporation Law ("BCL").  The complaint also alleges
     that the Company's Schedule 14D-9 is materially false and
     misleading in that it (i) impliedly represents that the Board of
     Directors of the Company had an informed basis upon which to
     recommend the merger with ICI when, in fact, the Board did not
     have such an informed basis; (ii) contains misrepresentations and
     omissions concerning Sherwin-Williams' repeated indications of
     interest in negotiating and consummating an acquisition of the
     Company; and (iii) misrepresents the terms and nature of the
     Corimon Option Agreement.

               The complaint in the Sherwin-Williams' Federal Action
     seeks, among other things, an order:  (i) preliminarily and
     permanently enjoining ICI and all other persons acting in concert
     with it, from acquiring or attempting to acquire the Company's
     Shares or continuing the ICI Offer; (ii) that ICI, GDEN and the
     Company make appropriate disclosures to correct the alleged false
     and misleading statements described above, and prohibiting ICI
     from purchasing or making any tender offer for Shares for an
     appropriate period to allow full dissemination of such
     disclosures to the marketplace and to the Company's shareholders;
     and (iii) enjoining the Company and all other persons acting in
     concert with them, from taking any steps to assist or facilitate
     the completion of the tender offer for the Company by GDEN or
     ICI.  The complaint also seeks costs, disbursements and
     reasonable attorneys' fees.

          (g)  On May 8, 1995, Sherwin-Williams commenced an action
     entitled The Sherwin-Williams Company v. Grow Group, Inc. et al.,
     in the Supreme Court of the State of New York (the "New York
     Action") against the Company, ICI, GDEN and members of the
     Company's Board of Directors (collectively, the "Defendants"). 
     The complaint in the New York Action alleges, among other things,
     that the Company and its Board of Directors breached their
     fiduciary duties to the Company's shareholders by, among other
     things, entering into the Merger Agreement and agreeing to the
     Corimon Option Agreement and the break-up fee without first
     negotiating with Sherwin-Williams or adequately considering
     potential alternative transactions available to the Company.  The
     complaint also alleges, among other things, that the Merger
     Agreement and proposed merger violate Section 912 of the BCL,
     which, according to the complaint, prevents the merger between
     ICI and the Company for five years.  The complaint further
     alleges that the Company's Board breached its fiduciary duty to
     make truthful and complete disclosures by (i) misleadingly
     stating that the transaction and proposed merger are fair to, and
     in the best interest of, the Company's shareholders when in fact
     it had no informed basis to make such a statement; and (ii)
     failing to disclose that the transaction and proposed merger
     violate Section 912 of the BCL.  The complaint in the New York
     Action seeks, among other things, (i) an order declaring that the
     Merger Agreement and the Corimon Option Agreement are null and
     void and unlawful and were entered into in breach of the
     fiduciary duties of the Company's Board; (ii) requiring the
     Company and the Board to provide Sherwin-Williams a fair and
     equal opportunity to acquire the Company; and (iii) enjoining any
     further conduct by ICI intended to cause, or having the effect of
     causing, the Company to forego the opportunity to enter into an
     economically more favorable transaction than the merger with ICI. 
     The complaint also seeks costs and disbursements, including
     attorneys' fees.

               On May 8, 1995, Sherwin-Williams moved by order to show
     cause for a hearing (the "Hearing") on a motion for a preliminary
     injunction, among other things, (i) enjoining defendants from
     taking any further steps to facilitate or consummate the ICI
     Offer; (ii) enjoining and invalidating the break-up fee; and
     (iii) directing the Company and the Board to investigate and
     explore all bona fide offers and proposals to acquire the
     Company, including the Sherwin-Williams' tender offer, and to
     remove all impediments to the Sherwin-Williams' tender offer.

               On May 8, 1995, Sherwin-Williams also moved by order to
     show cause for a temporary restraining order, pending the
     Hearing, (i) enjoining ICI from exercising any right under the
     Corimon Option Agreement to prevent Corimon from withdrawing any
     Shares that Corimon may tender into the Offer; and (ii) enjoining
     and directing the Company to provide Sherwin-Williams by 10:00
     a.m. on May 10, 1995 with a record of the names and addresses of
     the Company's shareholders, and the number and class of Shares
     held by each.

               At a hearing on May 8, 1995, the Court denied Sherwin-
     Williams' motion for a temporary restraining order.  The Court
     also scheduled a hearing for May 25, 1995 at 4:00 p.m. on
     Sherwin-Williams' motion for a preliminary injunction.

          (h)  On May 8, 1995, a purported class action entitled A.D.
     Gilhart & Co., Inc., v. Grow Group, Inc. et al., was commenced in
     the Supreme Court of the State of New York, New York County (the
     "Gilhart Action") against the Company and members of the
     Company's Board of Directors.  The complaint in the Gilhart
     Action alleges, among other things, that the defendants breached
     their fiduciary duties owed to the Company's shareholders in
     connection with the proposed merger between the Company and ICI
     by failing to pursue discussions with Sherwin-Williams about a
     possible acquisition of the Company by Sherwin-Williams.

               The complaint in the Gilhart Action seeks, among other
     things, an order (i) enjoining defendants from enforcing the
     Company's "anti-takeover procedures"; (ii) requiring defendants
     to explore third party interest and accept the highest bid
     obtainable for the Company's Shares; and (iii) awarding the
     plaintiffs' costs and disbursements, including attorneys' fees.

          (i)  On May 9, 1995, a purported class action entitled Kim
     J. Hammond and Jeffrey Dell v. Grow Group, Inc., et al. was
     commenced in the United States District Court for the Southern
     District of New York (the "Hammond Action") against the Company
     and certain members of the Company's Board of Directors
     (collectively, the "Defendants") on behalf of all persons who
     sold the Company's securities during the period from April 29,
     1995 to May 4, 1995 and who sustained damages as a result of such
     sale.  The complaint alleges violations of Section 10(b) of the
     Exchange Act and Rule 10b-5 promulgated thereunder for, among
     other things, issuing the statements contained in press releases
     dated April 28, 1995 and May 1, 1995 which allegedly were
     materially false and misleading for failing to adequately
     disclose all material facts concerning Sherwin-Williams' contacts
     with the Company regarding a proposed acquisition by Sherwin-
     Williams; and for falsely creating the impression that the Board
     of Directors had "shopped" the Company.  The complaint further
     alleges that the above-mentioned disclosures artificially
     affected the market price of the Company's securities.

               The complaint in the Hammond Action seeks, among other
     things, monetary damages against the Defendants in an unspecified
     amount for all losses suffered by the plaintiffs as a result of
     the allegedly improper activity of the Defendants and costs,
     reasonable attorneys' fees and expert fees and disbursements.

          (j)  On May 9, 1995, a purported class action entitled
     Kenneth Steiner v. Grow Group, Inc., et al., was commenced in the
     Supreme Court of the State of New York, New York County (the
     "Steiner Action") against the Company and certain current members
     and one former member of the Company's Board of Directors.  The
     complaint in the Steiner Action alleges, among other things, that
     the individual defendants breached their fiduciary duties to the
     purported class by excluding Sherwin-Williams from bidding for
     the Company, by failing to seek other bona fide bids and by
     failing to take adequate steps to maximize shareholder value.

               The complaint in the Steiner Action seeks, among other
     things, an order (i) declaring that the defendants breached their
     fiduciary duties to the purported class; (ii) preliminarily and
     permanently enjoining the purchase of the Company by ICI pursuant
     to the Merger Agreement; (iii) requiring defendants to negotiate
     with Sherwin-Williams and/or other potential acquirors to
     maximize shareholder value; and (iv) awarding plaintiffs'
     compensatory damages and costs and disbursements, including
     attorneys' fees and expert fees.

     Item 5.   Other Information.

          (a)  On March 23, 1995, the Company entered into Amendment
     No. 4 to the Credit Agreement dated as of March 31, 1993, among
     the Company, Grow Group Insurance, Ltd., Cello Corp., Sinclair-
     Ameritone Paint Corporation and Zynolyte Products Company,
     wholly-owned subsidiaries of the Company, and Chemical Bank New
     Jersey, N.A., Fleet Bank, PNC Bank, Kentucky, Inc., Wells Fargo
     Bank, N.A. and Chemical Bank (collectively, the "Banks"),
     pursuant to which the Bank extended the expiration date of the
     Company's credit facility from March 31, 1996 to March 31, 1997. 
     Reference is made to the Company's Current Reports on Form 8-K
     dated (date of earliest event reported) March 31, 1993 and August
     3, 1994 and the Company's Current Report on Form 10-Q for the
     quarter ended December 31, 1994 for further information
     concerning this credit facility.

          (b)  As noted in Item 1, "Legal Proceedings" above, on April
     30, 1995, the Company, Imperial Chemical Industries PLC, a
     corporation organized under the laws of England ("ICI"), and GDEN
     Corporation, a New York corporation and an indirect wholly-owned
     subsidiary of ICI ("GDEN"), entered into an Agreement and Plan of
     Merger, dated as of April 30, 1995 (the "Merger Agreement").

               The Merger Agreement provides, among other things, for
     the acquisition by ICI of all the outstanding shares of the
     Company's Common Stock, $.10 par value per share (the "Shares"),
     through (i) a tender offer (the "Offer") for all Shares for
     $18.10 per Share, net to the sellers thereof in cash (the "Per
     Share Amount"), subject to any amounts required to be withheld
     under applicable federal, state, or foreign income tax
     regulations and (ii) a second-step merger pursuant to which GDEN
     will merge with and into the Company (the "Merger") and all
     outstanding Shares (other than Shares held by the Company as
     treasury stock or owned by ICI, GDEN or any other subsidiary of
     ICI, and other than dissenting Shares) will be converted into the
     right to receive the Per Share Amount in cash, subject to any
     amounts required to be withheld under applicable federal, state,
     local or foreign income tax regulations.

               Corimon Corporation, a Delaware corporation ("Corimon
     Corp.") and Corimon S.A.C.A., a corporation organized under the
     laws of Venezuela ("Corimon"), have entered into an Option
     Agreement, dated as of April 30, 1995, with ICI and GDEN (the
     "Corimon Option Agreement"), pursuant to which Corimon Corp. has
     granted to ICI an option (the "Option") to purchase 4,025,841
     Shares (the "Corimon Shares") at a purchase price of $17.50 per
     Share, upon the terms and subject to the conditions set forth in
     the Corimon Option Agreement.

               The Merger Agreement, the Offer and the Corimon Option
     Agreement were more fully described and were previously reported
     in the Company's Current Report on Form 8-K dated (date of
     earliest event reported) April 30, 1995, under Item 5, "Other
     Events."

          (c)  On May 8, 1995, The Sherwin-Williams Company ("Sherwin-
     Williams") commenced an unsolicited tender offer to acquire all
     outstanding Shares of the Company at a price of $19.50 per Share.

               On May 10, 1995, the Company announced that its Board
     of Directors had authorized management of the Company and the
     Company's financial and legal advisors to engage in discussions
     and negotiations with Sherwin-Williams in connection with its
     unsolicited tender offer.

               On May 12, 1995, the Company and Sherwin-Williams
     entered into a Confidentiality Agreement and Sherwin-Williams
     commenced a due diligence review of the Company.

     Item 6.   Exhibits and Reports on Form 8-K.
               ________________________________

          (a)  Exhibits:
               ________

               4.1  Amendment No. 4, dated March 23, 1995, to the Credit
                    Agreement dated as of March 31, 1993, by and among the 
                    Company, Grow Group Insurance, Ltd., Cello Corp., Sinclair-
                    Ameritone Paint Corporation, Zynolyte Products Company,
                    Chemical Bank New Jersey, N.A., Fleet Bank, PNC Bank, 
                    Kentucky, Inc., Wells Fargo Bank N.A. and Chemical Bank.

               27.  Financial Data Schedule.

          (b)  Reports on Form 8-K.
               ____________________

          During the quarter ended March 31, 1995, the Company filed
     one Current Report on Form 8-K dated (date of earliest event
     reported) February 14, 1995, reporting under Item 5, "Other
     Events."  No financial statements were filed with that Report. 
     On May 1, 1995, the Company filed a Current Report on Form 8-K
     dated (date of earliest event reported) April 30, 1995, reporting
     under Item 5, "Other Events."  No financial statements were filed
     with that Report.

                                   SIGNATURES
                                   __________

          Pursuant to the requirements of the Securities Exchange Act
     of 1934, the registrant has duly caused this report to be signed
     on its behalf by the undersigned thereunto duly authorized.

                                        GROW GROUP, INC.

     Date:  May 12, 1995           By:  /s/ R. Banks              
                                        __________________________
                                        Russell Banks, President
                                        (Chief Executive Officer)

                                   By:  /s/ Frank V. Esser        
                                        __________________________
                                        Frank V. Esser, Treasurer
                                        (Chief Financial and Chief
                                         Accounting Officer)


                         EXHIBIT INDEX
                         _____________

     EXHIBIT NO.         DESCRIPTION                     PAGE NO.
     ___________         ___________                     ________

     4.1            Amendment No. 4, dated March 23,
                    1995, to the Credit Agreement 
                    dated as of March 31, 1993, by 
                    and among the Company, Grow 
                    Group Insurance, Ltd., Cello 
                    Corp., Sinclair-Ameritone 
                    Paint Corporation, Zynolyte 
                    Products Company, Chemical 
                    Bank New Jersey, N.A., Fleet 
                    Bank, PNC Bank, Kentucky, Inc., 
                    Wells Fargo Bank N.A. and 
                    Chemical Bank.

     27.            Financial Data Schedule.





                            EXHIBIT 4.1


          This Amendment No. 4 ("Amendment No. 4") dated March 23,
     1995 to the Credit Agreement dated as of March 31, 1993, as
     amended by Amendment No. 1 thereto dated August 6, 1993, Waiver,
     Consent and Amendment No. 2 thereto dated August 3, 1994 and
     Amendment No. 3 thereto dated December 7, 1994, is made by and
     among GROW GROUP, INC., a New York corporation (the "Borrower"),
     GROW GROUP INSURANCE, LTD., a Bermuda corporation ("Grow
     Insurance"), CELLO CORP., a Maryland corporation ("Cello"),
     SINCLAIR-AMERITONE PAINT CORPORATION, a California corporation
     (f/k/a SINCLAIR ACQUISITION CORP. and f/k/a AMERITONE PAINT
     CORPORATION) ("Ameritone"), ZYNOLYTE PRODUCTS COMPANY, a
     California corporation ("Zynolyte"), CHEMICAL BANK NEW JERSEY,
     N.A., a national banking association ("Chemical" or the "Agent"),
     FLEET BANK, a New York banking corporation ("Fleet"), PNC BANK,
     KENTUCKY, INC., a Kentucky banking corporation ("PNC"), WELLS
     FARGO BANK, N.A., a national banking association ("Wells Fargo";
     Chemical, Fleet, PNC and Wells Fargo sometimes herein each called
     a "Bank" and collectively, the "Banks") and Chemical Bank, a New
     York banking corporation (the "Issuing Bank").

                         W I T N E S S E T H:

     Section 1.  Recitals.
                 ________

          This Amendment No. 4 is made in contemplation of the
     following matters:

          1.1.  The Borrower, Grow Insurance, the Banks and the
     Issuing Bank have entered into a certain Credit Agreement dated
     as of March 31, 1993.  That original agreement was amended by
     Amendment No. 1 thereto dated August 6, 1993, Waiver, Consent and
     Amendment No. 2 thereto dated August 3, 1994 and Amendment No. 3
     thereto dated December 7, 1994 (the original agreement, as
     amended by said Amendment No. 1, Waiver, Consent and Amendment
     No. 2 and Amendment No. 3, being herein called the "Existing
     Credit Agreement").  Terms defined in the Existing Credit
     Agreement are used herein as therein defined unless otherwise
     defined herein.

          1.2.  The Borrower has requested, and the Banks and the
     Issuing Bank have agreed, to extend the Revolving Credit
     Expiration Date from March 31, 1996 to March 31, 1997, and to
     amend the Existing Credit Agreement and the other Loan Documents
     to reflect such extension.

          1.3.  The Borrower has requested, and the Banks have agreed,
     to increase the permitted amount of expenditures for fixed assets
     during any fiscal year as provided in Section 9.9 of the Existing
     Credit Agreement, from and after March 31, 1995 until the
     Revolving Credit Expiration Date, to an aggregate amount not to
     exceed $37,500,000 and an aggregate amount not to exceed
     $20,000,000 in any 12-month period, and to amend the Existing
     Credit Agreement and the other Loan Documents to reflect such
     increase.

          1.4.  It is a condition precedent to the Banks' agreement to
     enter into this Amendment No. 4 and in consideration of the
     Banks' agreement to extend the Revolving Credit Expiration Date,
     that the Borrower shall pay to the Banks an extension fee (the
     "Extension Fee") of $93,750, which represents one-eighth percent
     (1/8%) of the aggregate amount of the Commitments, such fee to be
     divided among the Banks in accordance with their Pro Rata Shares. 
     The Extension Fee shall be payable in full upon the execution of
     this Amendment No. 4.

          1.5.  The Borrower has requested the Banks and the Issuing
     Bank to enter into this Amendment No. 4 and the Banks and the
     Issuing Bank have agreed to enter into this Amendment No. 4 for
     the foregoing purposes.

     Section 2.  Amendments.
                 __________

          2.1.  Defined Terms.  The defined term "Revolving Credit
     Expiration Date" in Section 1.1 of the Existing Credit Agreement
     shall be, and hereby is, amended in its entirety to read as
     follows:

               "Revolving Credit Expiration Date" shall mean March 31, 1997."

          2.2.  Section 9.9.  Section 9.9 of the Existing Credit
     Agreement shall be, and hereby is, amended in its entirety to
     read as follows:

               "Section 9.9.  Capital Expenditures.
                              ____________________

               (a)  During the period July 1, 1994 to and including March 
          30, 1995, directly or indirectly (by way of the acquisition of the 
          securities of a Person or otherwise), make or commit to make any 
          expenditure for fixed assets if, after giving effect thereto, the 
          aggregate amount of all such expenditures for fixed assets incurred 
          by the Borrower and Subsidiaries during such period would exceed 
          $15,000,000; provided, however, that the amount expended for the 
          purchase by Ameritone of the assets of Sinclair pursuant to the 
          Sinclair Asset Purchase Agreement shall be specifically excluded 
          from the limitations imposed by the provisions of this 
          Section 9.9(a).

               (b)  From and after March 31, 1995 to and including the
          Revolving Credit Expiration Date, directly or indirectly (by, way 
          of the acquisition of the securities of a Person or otherwise), 
          make or commit to make any expenditure for fixed assets if, after 
          giving effect thereto, the aggregate amount of all such expenditures
          for fixed assets incurred by the Borrower and Subsidiaries during 
          such period would exceed $37,500,000 in the aggregate or would 
          exceed $20,000,000 in the aggregate in any 12-month period."

     Section 3.  Representations and Warranties.
                 ______________________________

               (a)  Except as provided in Section 5(a) of Wavier,
     Consent and Amendment No. 2, the Borrower hereby represents and
     warrants that each representation and warranty by the Borrower
     set forth in Article V of the Existing Credit Agreement is true
     and correct on and as of the date of this Amendment No. 4 as
     though made by the Borrower on and as of such date.

               (b)  Except as provided in Section 5(b) of Waiver,
     Consent and Amendment No. 2, each Corporate Guarantor hereby
     represents and warrants that each representation and warranty by
     the Corporate Guarantors set forth in Section 5 of the
     Subsidiaries' Guaranty is true and correct on and as of the date
     of this Amendment No. 4 as though made by such Corporate
     Guarantors on and as of such date.

     Section 4.  Reaffirmations.
                 ______________

               (a)  The Borrower and Grow Insurance each hereby
     restates and reaffirms the provisions of the Credit Agreement (as
     heretofore and hereby amended), confirms its absolute and
     unconditional obligations thereunder and expressly acknowledges
     and agrees that its obligations thereunder continue in full force
     and effect from and after the date hereof.  The Borrower hereby
     restates and reaffirms the provisions of the Parent Guaranty, the
     Pledge Agreement and the Borrower Security Agreement (as
     heretofore and hereby amended), confirms its absolute and
     unconditional guaranty and pledge (of the stock of Cello,
     Ameritone and Zynolyte) and grant of security interests and other
     obligations thereunder, and expressly acknowledges and agrees
     that its guaranty, pledge and grant of security interests and
     other obligations thereunder continue in full force and effect
     from and after the date hereof.  Cello, Ameritone and Zynolyte
     each hereby restates and reaffirms the provisions of the
     Subsidiaries' Guaranty and the Corporate Guarantors' Security
     Agreement (as heretofore and hereby amended), confirms its
     absolute and unconditional guaranty and grant of security
     interests and other obligations thereunder, and expressly
     acknowledges and agrees that its guaranty and grant of security
     interests and other obligations thereunder continue in full force
     and effect from and after the date hereof.

               (b)  The Borrower expressly acknowledges that the
     execution of this Amendment No. 4 or any actions taken by the
     Borrower, the Banks or the Issuing Bank in connection therewith
     shall not be deemed a release or waiver of any of the Borrower's
     obligations pursuant to the Parent Guaranty.

               (c)  Each of the Corporate Guarantors expressly
     acknowledges that the execution of this Amendment No. 4 or any
     actions taken by the Corporate Guarantors, the Banks or the
     Issuing Bank in connection therewith shall not be deemed a
     release or waiver of any of the Corporate Guarantors' obligations
     pursuant to the Subsidiaries' Guaranty.

     Section 5.  General.
                 _______

          This Amendment No. 4 is made pursuant to Section 14.1 of the
     Existing Credit Agreement, Section 8 of the Subsidiaries'
     Guaranty and Section 12 of the Corporate Guarantors' Security
     Agreement, and the Borrower, Grow Insurance, the Corporate
     Guarantors, the Banks and the Issuing Bank acknowledge that all
     provisions of the Existing Credit Agreement and the other Loan
     Documents, as amended or waived hereby, are and shall remain in
     full force and effect, and nothing herein contained shall be
     deemed a waiver of, or impair the effectiveness or enforceability
     of, any other terms or conditions of the Existing Credit
     Agreement or any of the other Loan Documents except as expressly
     stated herein.  From and after the date of this Amendment No. 4,
     each and every reference in any of the Loan Documents to the
     Credit Agreement or any other Loan Document is hereby amended to
     mean the Existing Credit Agreement or such other Loan Document as
     heretofore amended and as amended by this Amendment No. 4. 
     Nothing in Amendment No. 1, Waiver, Consent and Amendment No. 2,
     Amendment No. 3 or Amendment No. 4 shall be deemed to constitute
     the Borrower, Grow Insurance, Cello, Ameritone or Zynolyte a
     party to, or to make the respective Person obligated under, or to
     require the consent or signature of the respective Person for,
     any amendment, supplement, consent or waiver with respect to, any
     of the Credit Agreement, Parent Guaranty, Pledge Agreement,
     Borrower Security Agreement, Subsidiaries' Guaranty or Corporate
     Guarantors' Security Agreement, unless the particular Person was
     a party to the particular Loan Document on the Closing Date (or,
     as to Zynolyte, except for the Subsidiaries' Guaranty and
     Corporate Guarantors' Security Agreement, as to which it is a
     guarantor, pledgor and obligor as fully as though an original
     party thereto).

     Section 6.  Effectiveness.
                 _____________

          Anything in this Amendment No. 4 to the contrary
     notwithstanding, this Amendment No. 4 shall become effective
     when, and only when:  (a) it shall have been signed and delivered
     on behalf of all of the parties hereto; and (b) each Bank shall
     have received its Pro Rata Share of the Extension Fee.
     Section 7.  Expenses of the Agent and the Banks.  Pursuant to
     Section 16.3 of the Existing Credit Agreement, the Borrower shall
     pay on demand to the Agent and the Banks, the reasonable out-of-
     pocket expenses of the Agent and each Bank, including, but not
     limited to the reasonable fees and expenses of Special Counsel
     and counsel for each Bank.

     Section 8.  Counterparts.
                 ____________

          This Amendment No. 4 may be executed in any number of
     counterparts, each of which shall be an original and all of which
     shall constitute one agreement.  It shall not be necessary in
     making proof of this Amendment No. 4 or of any document required
     to be executed and delivered in connection herewith or therewith
     to produce or account for more than one counterpart.

               IN WITNESS WHEREOF, the parties hereto have caused this
     Amendment No. 4 to be executed by their respective officers
     thereunto duly authorized, as of the date first above written.

                              GROW GROUP, INC.

                              By: _________________________________

                              GROW GROUP INSURANCE, LTD.

                              By: _________________________________

                              CELLO CORP.

                              By: __________________________________

                              SINCLAIR-AMERITONE PAINT CORPORATION
                              (f/k/a Sinclair Acquisition Corp. and
                               f/k/a Ameritone Paint Corporation)

                              By: __________________________________

                              ZYNOLYTE PRODUCTS COMPANY

                              By: __________________________________

                              CHEMICAL BANK NEW JERSEY, N.A.

                              By: __________________________________

                              FLEET BANK

                              By: __________________________________

                              PNC BANK, KENTUCKY, INC.

                              By: __________________________________

                              WELLS FARGO BANK, N.A.

                              By: __________________________________

                              CHEMICAL BANK

                              By: ___________________________________

<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1995
<PERIOD-END>                               MAR-31-1995
<CASH>                                       5,084,000
<SECURITIES>                                         0
<RECEIVABLES>                               74,559,000
<ALLOWANCES>                                 4,814,000
<INVENTORY>                                 86,324,000
<CURRENT-ASSETS>                           178,111,000
<PP&E>                                     136,119,000
<DEPRECIATION>                              52,740,000
<TOTAL-ASSETS>                             286,548,000
<CURRENT-LIABILITIES>                       85,339,000
<BONDS>                                              0
<COMMON>                                     1,627,000
                                0
                                          0
<OTHER-SE>                                 138,580,000
<TOTAL-LIABILITY-AND-EQUITY>               286,548,000
<SALES>                                    364,063,000
<TOTAL-REVENUES>                           364,063,000
<CGS>                                      234,510,000
<TOTAL-COSTS>                              355,942,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                             1,848,000
<INTEREST-EXPENSE>                           1,928,000
<INCOME-PRETAX>                              8,125,000
<INCOME-TAX>                                 3,573,000
<INCOME-CONTINUING>                          4,548,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 4,548,000
<EPS-PRIMARY>                                      .28
<EPS-DILUTED>                                      .28
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission